Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 4RCH | P35557 | Discovery of 2-Pyridyl Ureas as Glucokinase Activators | |
| 7T78 | P35557 | CRYSTAL STRUCTURE OF GLUCOKINASE (HEXOKINASE 4) COMPLEXED WITH LIGAND DIETHYL ({2-[3-(4-METHANESULFONYLPHENO XY)-5-{[(2S)-1-METHOXYPROPAN-2-YL]OXY}BENZAMIDO]-1,3-THIAZ OL-4-YL}METHYL)PHOSPHONATE | |
| 7T79 | P35557 | CRYSTAL STRUCTURE OF GLUCOKINASE (HEXOKINASE 4) COMPLEXED WITH LIGAND AKA DIETHYL {[3-(3-{[5-(AZETIDINE-1-CARBON YL)PYRAZIN-2-YL]OXY}-5-(PROPAN-2-YLOXY)BENZAMIDO)-1H- PYRAZOL-1-YL]METHYL}PHOSPHONATE | |
| 6AGF | P35499 | Structure of the human voltage-gated sodium channel Nav1.4 in complex with beta1 | Sodium channel protein PaFPC1, Mu-diguetoxin-Dc1a |
| 7DTD | P35498 | Voltage-gated sodium channel Nav1.1 and beta4 | Sodium channel subunit beta-4, Sodium channel protein type 1 subunit alpha |
| 6I6R | P35475 | New Irreversible a-l-Iduronidase Inhibitors and Activity-Based Probes | |
| 6I6X | P35475 | New Irreversible a-l-Iduronidase Inhibitors and Activity-Based Probes | |
| 3W81 | P35475 | Human alpha-l-iduronidase | Alpha-L-iduronidase (E.C.3.2.1.76) |
| 3W82 | P35475 | Human alpha-L-iduronidase in complex with iduronic acid | |
| 4KGJ | P35475 | Crystal structure of human alpha-L-iduronidase complex with 5-fluoro-alpha-L-idopyranosyluronic acid fluoride | |
| 4KGL | P35475 | Crystal structure of human alpha-L-iduronidase complex with [2R,3R,4R,5S]-2-carboxy-3,4,5-trihydroxy-piperidine | |
| 4KH2 | P35475 | Crystal structure of human alpha-L-iduronidase complex with 2-deoxy-2-fluoro-alpha-L-idopyranosyluronic acid fluoride | |
| 4MJ2 | P35475 | Crystal structure of apo-iduronidase in the R3 form | Alpha-L-iduronidase (E.C.3.2.1.76) |
| 4MJ4 | P35475 | Human iduronidase apo structure P21 form | |
| 4OBR | P35475 | Crystal structure of human alpha-L-iduronidase complex with alpha-L-iduronic acid | |
| 4OBS | P35475 | Crystal structure of human alpha-L-iduronidase in the P212121 form | |
| 3PBL | P35462 | Structure of the human dopamine D3 receptor in complex with eticlopride | |
| 6AEX | P35456 | Crystal structure of unoccupied murine uPAR | |
| 3LAQ | P35456 | Structure-based engineering of species selectivity in the uPA-uPAR interaction | Urokinase-type plasminogen activator (E.C.3.4.21.73), Urokinase plasminogen activator surface receptor |
| 1YO8 | P35442 | Structure of the C-terminal domain of human thrombospondin-2 | thrombospondin-2 |
| 2RHP | P35442 | The Thrombospondin-1 Polymorphism Asn700Ser Associated with Cornoary Artery Disease Causes Local and Long-Ranging Changes in Protein Structure | |
| 6MMJ | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the 'Super-Splayed' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6MMM | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended-1' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6MMW | P35439 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6MMB | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the 'Super-Splayed' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6MMT | P35439 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6MMU | P35439 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6WHU | P35439 | GluN1b-GluN2B NMDA receptor in complex with SDZ 220-040 and L689,560, class 1 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
| 6MM9 | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6WHV | P35439 | GluN1b-GluN2B NMDA receptor in complex with SDZ 220-040 and L689,560, class 2 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
| 6MMG | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar EDTA, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6MMK | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6MMS | P35439 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar EDTA, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6WHR | P35439 | GluN1b-GluN2B NMDA receptor in non-active 2 conformation at 4 angstrom resolution | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
| 6CNA | P35439 | GluN1-GluN2B NMDA receptors with exon 5 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
| 6MMA | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6WHT | P35439 | GluN1b-GluN2B NMDA receptor in active conformation at 4.4 angstrom resolution | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
| 6MMI | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the 'Splayed-Open' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6MML | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6MMX | P35439 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6MMH | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended-2' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6MMP | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar EDTA, and at pH 8.0 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6MMR | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar EDTA, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6MMN | P35439 | Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 8.0 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6WI0 | P35439 | GluN1b-GluN2B NMDA receptor in complex with GluN1 antagonist L689,560, class 2 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
| 3Q41 | P35439 | Crystal structure of the GluN1 N-terminal domain (NTD) | Glutamate [NMDA] receptor subunit zeta-1 |
| 4PE5 | P35439 | Crystal Structure of GluN1a/GluN2B NMDA Receptor Ion Channel | |
| 6MMV | P35439 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* Extracellular Domain in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A |
| 6WHS | P35439 | GluN1b-GluN2B NMDA receptor in non-active 1 conformation at 3.95 angstrom resolution | Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B |
| 7YFG | P35439 | Structure of the Rat GluN1-GluN2C NMDA receptor in complex with glycine and glutamate (major class in asymmetry) |
